Two Minnesota device manufacturers combine to make Forj Medical

The chief executive of the vertically integrated Arden Hills-based firm said the entity has not planned large restructuring and workforce reductions.

The Minnesota Star Tribune
October 9, 2025 at 3:59PM
The production facility at Minnetronix in St. Paul on Wednesday, August 5, 2015. ] LEILA NAVIDI leila.navidi@startribune.com / BACKGROUND INFORMATION: Minnetronix is marketing a new technology that allows the batteries in implantable medical devices to be recharged wirelessly. The technology works by transmitting energy through the skin to the device, without needing to break the skin itself, reducing infection risk and improving patient comfort. A St. Paul company called Minnetronix has develop
The production facility at Minnetronix in St. Paul in 2015. The company is combining with another to form Forj Medical. (Leila Navidi/The Minnesota Star Tribune)

Two Minnesota manufacturers making medical devices and components for other companies are combining to command more stages of the medtech supply chain.

Altaris Capital Partners, a New York-based private equity firm, is combining its Minnesota companies Minnetronix Medical and Intricon to create Forj Medical, offering system design, precision molding, microelectronics and advanced manufacturing services. Jeremy Maniak, who was CEO of Minnetronix, will helm the new firm as chief executive.

“Both businesses were in a good place — good customer bases, good growth prospects, doing well financially — and so the time really felt like it was right to find the next gear," Maniak said.

The companies did not release any financial terms of the merger.

The new firm, headquartered in Arden Hills, employs more than 900 workers spread across six facilities in the United States, Indonesia, Singapore and Costa Rica. The company isn’t planning or expecting any restructuring and workforce reductions, Maniak said. A lot of the teams and capabilities of the two companies are not overlapping but rather complementary, he added.

“What they did capabilities-wise, what we did capabilities-wise, we’re going to keep doing,” Maniak said.

The merger comes as tariffs continue to roil the medical device supply chain, with more potentially on the way. Large device firms rely on contract design and manufacturing companies such as Forj for stable manufacturing services, which in recent years have become more difficult following pandemic-related supply chain issues and now the extra import taxes.

Maniak described the business atmosphere as volatile for these manufacturers.

“Forj Medical … will have a solid year. But I think it takes more work than it ever has to do that, because you’re solving tariff problems constantly,” Maniak said. “Things that came up once a month now come up every day.”

The transaction combines two firms with decadeslong histories in Minnesota.

Intricon was founded in 1977 with the creation of a hearing aid, and the company now makes small devices and components in the diabetes, neuromodulation, cardiology and orthopedics sectors for other firms.

Altaris acquired Intricon for $241 million in 2022. In 2024, Intricon sold its hearing business to a Chinese medtech company after its over-the-counter products failed to take off.

Minnetronix was founded in 1996 in St. Paul. Maniak said it is focused on building large and highly technical capital equipment powering devices and advanced medical technology systems. Altaris acquired a majority stake in 2021.

“The customer feedback as we’ve kind of announced ... has been phenomenal, which is the best indicator that we’re doing something right,” Maniak said.

about the writer

about the writer

Victor Stefanescu

Reporter

Victor Stefanescu covers medical technology startups and large companies such as Medtronic for the business section. He reports on new inventions, patients’ experiences with medical devices and the businesses behind med-tech in Minnesota.

See Moreicon

More from Health Care

See More
card image
Leila Navidi/The Minnesota Star Tribune

Following concerns that Medtronic was overspending on the high-tech system and not developing it fast enough, FDA clearance is a major victory for the Minnesota-run medtech company.

Nancy Ingham gives newborn Sophia Rash a hepatitis B shot several hours after she was born, Jan. 17, 2006.
card image